The multifaceted role of TRAIL signaling in cancer and immunity - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue FEBS Journal Année : 2021

The multifaceted role of TRAIL signaling in cancer and immunity

Résumé

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) is a member of the TNF superfamily that can lead to the induction of apoptosis in tumor or infected cells. However, activation of TRAIL signaling may also trigger nonapoptotic pathways in cancer and in nontransformed cells, that is, immune cells. Here, we review the current knowledge on noncanonical TRAIL signaling. The biological outcomes of TRAIL signaling in immune and malignant cells are presented and explained, with a focus on the role of TRAIL for natural killer (NK) cell function. Furthermore, we highlight the technical difficulties in dissecting the precise molecular mechanisms involved in the switch between apoptotic and nonapoptotic TRAIL signaling. Finally, we discuss the consequences thereof for a therapeutic manipulation of TRAIL in cancer and possible approaches to bypass these difficulties.
Fichier sous embargo
Fichier sous embargo
Date de visibilité indéterminée

Dates et versions

inserm-03516752 , version 1 (07-01-2022)

Identifiants

Citer

Ludmila Cardoso Alves, Nadia Corazza, Olivier Micheau, Philippe Krebs. The multifaceted role of TRAIL signaling in cancer and immunity. FEBS Journal, 2021, 288 (19), pp.5530-5554. ⟨10.1111/febs.15637⟩. ⟨inserm-03516752⟩
19 Consultations
19 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More